|
Market Closed -
Nasdaq
04:00:00 2026-08-21 pm EDT
|
5-day change | 1st Jan Change | ||
| 548.05 USD | +1.44% |
|
+8.36% | +20.89% |
| Aug. 12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| Aug. 11 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
VRTX 548.05 $
+1.44%
589M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| VRTX | 548.05USD | +1.44% | 589M $ | |
CBOE
| VRTX | 548.23USD | +1.49% | 11.38M $ | |
|
Tradegate
| VX1 | 469.30EUR | +1.47% | 138K € | |
|
Mexican S.E.
| VRTX * | 9,410.00MXN | +2.25% | 1.33M $ | |
|
Boerse Muenchen
| VX1 | 468.75EUR | +1.44% | 34.69K € | |
|
Xetra
| VX1 | 472.05EUR | +0.76% | 25.02K € | |
|
Wiener Boerse
| VRTX | 472.00EUR | +0.52% | 22.66K € | |
|
Deutsche Boerse AG
| VX1 | 468.20EUR | -0.58% | 16.39K € | |
|
London S.E.
| 0QZU | 526.81USD | +4.79% | 12.12K $ | |
|
Borsa Italiana
| 1VRTX | 469.25EUR | +0.56% | 10.79K € | |
|
CBOE
| 0QZU | 474.05EUR | +8.24% | 2.37K € | |
|
Börse Stuttgart
| VX1 | 468.80EUR | +1.64% | 0 € | |
|
CBOE
| 464.20EUR | 0.00% | 0 € | ||
Sao Paulo
| VRTX34 | 88.28BRL | -84.76% | 1.06K R$ | |
Buenos Aires S.E.
| VRTX | 8,625.00ARS | +2.13% | 45.42M $ | |
|
Buenos Aires S.E.
| VRTXD | 5.720USD | +1.78% | 97.24 $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 552.06 | 552.06 | 600.34 |
| Spread/Res. | -0.73% | -0.73% | -8.71% |
| Spread/Supp. | +8.36% | +16.43% | +20.00% |
| Support | 505.75 | 470.72 | 456.69 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VRTX Stock
- Charts Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
